CA2712987C - Compositions and methods for influencing recovery from strenuous physical activity - Google Patents
Compositions and methods for influencing recovery from strenuous physical activity Download PDFInfo
- Publication number
- CA2712987C CA2712987C CA2712987A CA2712987A CA2712987C CA 2712987 C CA2712987 C CA 2712987C CA 2712987 A CA2712987 A CA 2712987A CA 2712987 A CA2712987 A CA 2712987A CA 2712987 C CA2712987 C CA 2712987C
- Authority
- CA
- Canada
- Prior art keywords
- composition
- protein
- carbohydrate
- exercise
- physical activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 265
- 238000011084 recovery Methods 0.000 title claims abstract description 121
- 230000037081 physical activity Effects 0.000 title claims abstract description 110
- 238000000034 method Methods 0.000 title abstract description 49
- 241001465754 Metazoa Species 0.000 claims abstract description 122
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 120
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 120
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 75
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 58
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 58
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 40
- 229920002472 Starch Polymers 0.000 claims abstract description 32
- 235000019698 starch Nutrition 0.000 claims abstract description 32
- 239000008107 starch Substances 0.000 claims abstract description 32
- 229920002245 Dextrose equivalent Polymers 0.000 claims description 109
- 235000015895 biscuits Nutrition 0.000 claims description 106
- 229940024606 amino acid Drugs 0.000 claims description 77
- 235000001014 amino acid Nutrition 0.000 claims description 77
- 150000001413 amino acids Chemical class 0.000 claims description 77
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 70
- 239000008280 blood Substances 0.000 claims description 65
- 210000004369 blood Anatomy 0.000 claims description 65
- 235000018102 proteins Nutrition 0.000 claims description 57
- 235000013305 food Nutrition 0.000 claims description 50
- 239000008103 glucose Substances 0.000 claims description 47
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 41
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 39
- 239000005913 Maltodextrin Substances 0.000 claims description 39
- 235000006708 antioxidants Nutrition 0.000 claims description 39
- 230000006378 damage Effects 0.000 claims description 39
- 229940035034 maltodextrin Drugs 0.000 claims description 39
- 108010046377 Whey Proteins Proteins 0.000 claims description 33
- 102000007544 Whey Proteins Human genes 0.000 claims description 33
- 235000021119 whey protein Nutrition 0.000 claims description 33
- 108010068370 Glutens Proteins 0.000 claims description 32
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 32
- 240000008042 Zea mays Species 0.000 claims description 32
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 32
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 32
- 239000001168 astaxanthin Substances 0.000 claims description 32
- 229940022405 astaxanthin Drugs 0.000 claims description 32
- 235000005822 corn Nutrition 0.000 claims description 32
- 235000021312 gluten Nutrition 0.000 claims description 32
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 28
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 28
- 235000013793 astaxanthin Nutrition 0.000 claims description 28
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 28
- 239000004475 Arginine Substances 0.000 claims description 26
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 26
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 26
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 26
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 26
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 26
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 26
- 235000013922 glutamic acid Nutrition 0.000 claims description 26
- 239000004220 glutamic acid Substances 0.000 claims description 26
- 229960000310 isoleucine Drugs 0.000 claims description 26
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 26
- 239000004474 valine Substances 0.000 claims description 26
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 25
- 230000001603 reducing effect Effects 0.000 claims description 24
- 239000008121 dextrose Substances 0.000 claims description 23
- 235000012054 meals Nutrition 0.000 claims description 22
- 235000021466 carotenoid Nutrition 0.000 claims description 21
- 150000001747 carotenoids Chemical class 0.000 claims description 21
- 235000019750 Crude protein Nutrition 0.000 claims description 20
- 239000012141 concentrate Substances 0.000 claims description 20
- 235000013312 flour Nutrition 0.000 claims description 20
- 229920002527 Glycogen Polymers 0.000 claims description 19
- 229940096919 glycogen Drugs 0.000 claims description 19
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 18
- 241000168517 Haematococcus lacustris Species 0.000 claims description 16
- 230000036542 oxidative stress Effects 0.000 claims description 16
- 230000003078 antioxidant effect Effects 0.000 claims description 15
- 210000003205 muscle Anatomy 0.000 claims description 15
- 230000001965 increasing effect Effects 0.000 claims description 13
- 241000209094 Oryza Species 0.000 claims description 12
- 235000007164 Oryza sativa Nutrition 0.000 claims description 12
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 12
- 235000009566 rice Nutrition 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 10
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 10
- 229920000881 Modified starch Polymers 0.000 claims description 10
- 239000004368 Modified starch Substances 0.000 claims description 10
- 239000011575 calcium Substances 0.000 claims description 10
- 229910052791 calcium Inorganic materials 0.000 claims description 10
- 210000004185 liver Anatomy 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 10
- 235000019426 modified starch Nutrition 0.000 claims description 10
- 230000035882 stress Effects 0.000 claims description 10
- 230000015556 catabolic process Effects 0.000 claims description 9
- 208000024891 symptom Diseases 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000011591 potassium Substances 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- 206010061218 Inflammation Diseases 0.000 claims description 7
- 241000209140 Triticum Species 0.000 claims description 7
- 235000021307 Triticum Nutrition 0.000 claims description 7
- 235000012680 lutein Nutrition 0.000 claims description 7
- 239000001656 lutein Substances 0.000 claims description 7
- 229960005375 lutein Drugs 0.000 claims description 7
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 7
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 7
- 210000001087 myotubule Anatomy 0.000 claims description 7
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 7
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical group OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 6
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 claims description 6
- 230000004054 inflammatory process Effects 0.000 claims description 6
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 5
- 239000005715 Fructose Substances 0.000 claims description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 5
- 229930182830 galactose Natural products 0.000 claims description 5
- 230000002503 metabolic effect Effects 0.000 claims description 5
- 239000002438 stress hormone Substances 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 230000014616 translation Effects 0.000 claims description 5
- 230000004075 alteration Effects 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims description 4
- 238000013461 design Methods 0.000 claims description 4
- 229960003136 leucine Drugs 0.000 claims description 4
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 230000009885 systemic effect Effects 0.000 claims description 4
- 229960004295 valine Drugs 0.000 claims description 4
- 108010064851 Plant Proteins Proteins 0.000 claims description 3
- 241000694540 Pluvialis Species 0.000 claims description 3
- 235000021120 animal protein Nutrition 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 238000006213 oxygenation reaction Methods 0.000 claims description 3
- 235000021118 plant-derived protein Nutrition 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 239000003531 protein hydrolysate Substances 0.000 claims description 3
- 208000013016 Hypoglycemia Diseases 0.000 claims description 2
- 238000010791 quenching Methods 0.000 claims description 2
- 230000000171 quenching effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 68
- 230000000977 initiatory effect Effects 0.000 abstract description 9
- 241000282472 Canis lupus familiaris Species 0.000 description 91
- 239000003795 chemical substances by application Substances 0.000 description 22
- 239000003814 drug Substances 0.000 description 17
- 241000282414 Homo sapiens Species 0.000 description 15
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 14
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 230000004044 response Effects 0.000 description 13
- 238000012360 testing method Methods 0.000 description 11
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 10
- 108010082126 Alanine transaminase Proteins 0.000 description 10
- 230000007423 decrease Effects 0.000 description 10
- 235000015872 dietary supplement Nutrition 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 230000001413 cellular effect Effects 0.000 description 8
- 230000002641 glycemic effect Effects 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 230000001149 cognitive effect Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 102000004420 Creatine Kinase Human genes 0.000 description 6
- 108010042126 Creatine kinase Proteins 0.000 description 6
- 230000003542 behavioural effect Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000007659 motor function Effects 0.000 description 6
- 230000003405 preventing effect Effects 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 208000000112 Myalgia Diseases 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 210000000663 muscle cell Anatomy 0.000 description 5
- 208000015001 muscle soreness Diseases 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 235000011888 snacks Nutrition 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000282465 Canis Species 0.000 description 4
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 208000029549 Muscle injury Diseases 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000036765 blood level Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 239000003760 tallow Substances 0.000 description 4
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 241000195493 Cryptophyta Species 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 235000021472 generally recognized as safe Nutrition 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229940057917 medium chain triglycerides Drugs 0.000 description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 206010007733 Catabolic state Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000282324 Felis Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 235000020938 metabolic status Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- -1 muscle protein Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000032696 parturition Effects 0.000 description 2
- 230000003244 pro-oxidative effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000699694 Gerbillinae Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008455 cerebrovascular function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020650 eye health related herbal supplements Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000008798 inflammatory stress Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 231100000647 material safety data sheet Toxicity 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006609 metabolic stress Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000011273 social behavior Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000037221 weight management Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Birds (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6391808P | 2008-02-07 | 2008-02-07 | |
| US61/063,918 | 2008-02-07 | ||
| PCT/US2009/000741 WO2009099628A2 (en) | 2008-02-07 | 2009-02-05 | Compositions and methods for influencing recovery from strenuous physical activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2712987A1 CA2712987A1 (en) | 2009-08-13 |
| CA2712987C true CA2712987C (en) | 2016-05-17 |
Family
ID=40952609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2712987A Expired - Fee Related CA2712987C (en) | 2008-02-07 | 2009-02-05 | Compositions and methods for influencing recovery from strenuous physical activity |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9107867B2 (enExample) |
| EP (1) | EP2240185B1 (enExample) |
| JP (1) | JP5391208B2 (enExample) |
| CN (1) | CN101939011B (enExample) |
| AU (1) | AU2009210728B2 (enExample) |
| BR (1) | BRPI0908414A2 (enExample) |
| CA (1) | CA2712987C (enExample) |
| ES (1) | ES2483735T3 (enExample) |
| MX (1) | MX2010008726A (enExample) |
| RU (1) | RU2500406C2 (enExample) |
| WO (1) | WO2009099628A2 (enExample) |
| ZA (1) | ZA201006383B (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2098124A1 (en) | 2008-03-03 | 2009-09-09 | Nestec S.A. | Carbohydrate gel |
| RU2013151680A (ru) * | 2011-04-21 | 2015-05-27 | Нестек С.А. | Питательные композиции для улучшения выступления, способы их получения и применения |
| US10194674B2 (en) | 2011-09-01 | 2019-02-05 | John C. Gilkey | Nutritional compositions |
| US20130059038A1 (en) * | 2011-09-01 | 2013-03-07 | John C. Gilkey | Nutritional composition |
| CN104769128B (zh) | 2011-11-07 | 2020-11-06 | 马斯公司 | 食物蛋白质成分及制备方法 |
| DE102012108843A1 (de) * | 2012-09-20 | 2014-03-20 | Pm-International Ag | Sportgetränk mit kurz- und langkettigen Kohlenhydratkomponenten |
| DE102012108840A1 (de) * | 2012-09-20 | 2014-03-20 | Pm-International Ag | Sportgetränk mit Algenpulver |
| DE102012108841A1 (de) * | 2012-09-20 | 2014-03-20 | Pm-International Ag | Sportgetränk |
| US9232815B2 (en) * | 2012-10-25 | 2016-01-12 | Run Them Sweet, LLC | Blood lactate range targets and nutritional formulations and protocols to support patients |
| US10206422B2 (en) * | 2012-10-25 | 2019-02-19 | Run Them Sweet Llc | Systems and methods for monitoring of blood lactate and targeting of blood lactate via nutritional support |
| WO2014066628A2 (en) * | 2012-10-25 | 2014-05-01 | Run Them Sweet, LLC | Methods and systems to estimate nutritional needs of human and other patients and to support such nutritional needs |
| WO2014191856A1 (en) * | 2013-05-31 | 2014-12-04 | Nestec S.A. | Methods for enhancement of muscle protein synthesis |
| US10420783B2 (en) | 2013-06-20 | 2019-09-24 | Mars, Incorporated | Performance food product |
| WO2014209791A1 (en) | 2013-06-28 | 2014-12-31 | Nestec Sa | Compositions and methods for enhancing exercise performance |
| WO2015002527A1 (en) * | 2013-07-05 | 2015-01-08 | N.V. Nutricia | Amino acid composition for use in the treatment of a pdd |
| GB201413761D0 (en) * | 2014-08-04 | 2014-09-17 | Ketolife Ltd | Nutritional gel composition |
| HK1256598A1 (zh) * | 2015-07-30 | 2019-09-27 | 奥特丽公司 | 植物保健饮料 |
| AU2016370709B2 (en) * | 2015-12-18 | 2020-10-29 | Société des Produits Nestlé S.A. | Hydration for animals |
| US11412770B2 (en) | 2015-12-25 | 2022-08-16 | Otsuka Pharmaceutical Co., Ltd. | Gel-like food composition |
| PL3435786T3 (pl) * | 2016-04-01 | 2020-12-14 | Dsm Ip Assets B.V. | Napoje zawierające stabilne granulki mielonej luteiny |
| USD805728S1 (en) | 2016-09-06 | 2017-12-26 | Mars, Incorporated | Food product |
| USD806351S1 (en) | 2016-09-06 | 2018-01-02 | Mars, Incorporated | Food product |
| CN106616980B (zh) * | 2016-12-07 | 2021-02-12 | 北京康比特体育科技股份有限公司 | 促进力量训练后肌肉合成的组合物及其制备方法 |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| GB201701417D0 (en) | 2017-01-27 | 2017-03-15 | Mars Inc | Pet food |
| SG11202001142VA (en) | 2017-08-14 | 2020-03-30 | Axcella Health Inc | Amino acid compositions for the treatment of liver disease |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
| US10596136B2 (en) | 2018-06-20 | 2020-03-24 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2991181A (en) * | 1958-05-29 | 1961-07-04 | Salada Shirriff Horsey Inc | Cereal and method of making same |
| US5194284A (en) * | 1988-10-14 | 1993-03-16 | National Starch And Chemical Investment Holding Corporation | Foods opacified with debranched starch |
| US5795602A (en) * | 1996-04-12 | 1998-08-18 | Cargill, Incorporated | Milk enhancer and milk feed composition |
| AU2926499A (en) | 1999-02-17 | 2000-09-04 | Amylum Belgium N.V. | Calf milk replacer |
| EP1163852A4 (en) | 1999-02-18 | 2002-06-12 | Fujisawa Pharmaceutical Co | Masking agent |
| IL147044A0 (en) * | 1999-07-06 | 2002-08-14 | Nestle Sa | Gelled nutritional composition and process |
| CN1638650A (zh) * | 2001-03-09 | 2005-07-13 | 雀巢制品公司 | 改善与年龄有关的生理缺陷并延长寿命的组合物 |
| AU2002255913B2 (en) * | 2001-03-27 | 2007-10-18 | Syngenta Seeds, Inc. | Uses of white corn hybrids |
| US20030143311A1 (en) * | 2001-10-26 | 2003-07-31 | William Gillota | Recovery drink formula and method |
| US7498039B2 (en) * | 2002-10-10 | 2009-03-03 | Thompson Diana F | Nutritional supplement containing sea water minerals |
| US20040096547A1 (en) | 2002-11-15 | 2004-05-20 | Mario Ferruzzi | Healthy alternative ready-to-drink energy beverage |
| US8034372B2 (en) * | 2003-03-05 | 2011-10-11 | Nestec, Ltd. | Dietary supplement for athletic pets |
| US20040219188A1 (en) * | 2003-05-02 | 2004-11-04 | Comer Gail M. | Composition and methods for nutritional management of patients with hepatic disease |
| WO2005039318A1 (en) * | 2003-10-16 | 2005-05-06 | Nestec S.A. | Nutritional composition against side effects of chemotherapy of radiotherapy |
| US8734873B2 (en) * | 2004-04-07 | 2014-05-27 | Archer Daniels Medical Company | Food bar with reduced hardness |
| CN101043820A (zh) * | 2004-10-22 | 2007-09-26 | 西姆莱斯有限责任两合公司 | 适合消费的压缩香味剂团块 |
| WO2007056176A2 (en) * | 2005-11-03 | 2007-05-18 | Southwest Immunology, Inc. | Compositions for preventing and reducing delayed onset muscle soreness |
| ES2363442T3 (es) * | 2005-11-30 | 2011-08-04 | Nestec S.A. | Combinación que comprende al menos una aminoácido y un inhibidor de pkr para utilizar en el tratamiento de la pérdida de masa muscular. |
| MX2008011958A (es) * | 2006-03-29 | 2008-10-01 | Nestec Sa | Suplementos dieteticos que contienen probioticos. |
-
2009
- 2009-02-05 EP EP09708017.0A patent/EP2240185B1/en active Active
- 2009-02-05 MX MX2010008726A patent/MX2010008726A/es active IP Right Grant
- 2009-02-05 AU AU2009210728A patent/AU2009210728B2/en not_active Ceased
- 2009-02-05 BR BRPI0908414-2A patent/BRPI0908414A2/pt not_active Application Discontinuation
- 2009-02-05 ES ES09708017.0T patent/ES2483735T3/es active Active
- 2009-02-05 JP JP2010545874A patent/JP5391208B2/ja not_active Expired - Fee Related
- 2009-02-05 WO PCT/US2009/000741 patent/WO2009099628A2/en not_active Ceased
- 2009-02-05 US US12/735,651 patent/US9107867B2/en active Active
- 2009-02-05 CN CN2009801045539A patent/CN101939011B/zh not_active Expired - Fee Related
- 2009-02-05 CA CA2712987A patent/CA2712987C/en not_active Expired - Fee Related
- 2009-02-05 RU RU2010137117/15A patent/RU2500406C2/ru not_active IP Right Cessation
-
2010
- 2010-09-06 ZA ZA2010/06383A patent/ZA201006383B/en unknown
-
2015
- 2015-07-13 US US14/797,766 patent/US10624937B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2010137117A (ru) | 2012-03-20 |
| MX2010008726A (es) | 2010-08-31 |
| CN101939011B (zh) | 2012-10-10 |
| CN101939011A (zh) | 2011-01-05 |
| US10624937B2 (en) | 2020-04-21 |
| JP2011511070A (ja) | 2011-04-07 |
| US9107867B2 (en) | 2015-08-18 |
| AU2009210728A1 (en) | 2009-08-13 |
| US20110052753A1 (en) | 2011-03-03 |
| EP2240185A2 (en) | 2010-10-20 |
| US20150313262A1 (en) | 2015-11-05 |
| JP5391208B2 (ja) | 2014-01-15 |
| AU2009210728B2 (en) | 2014-06-19 |
| ZA201006383B (en) | 2012-02-29 |
| BRPI0908414A2 (pt) | 2015-08-04 |
| CA2712987A1 (en) | 2009-08-13 |
| WO2009099628A2 (en) | 2009-08-13 |
| RU2500406C2 (ru) | 2013-12-10 |
| EP2240185B1 (en) | 2014-06-25 |
| WO2009099628A3 (en) | 2009-10-29 |
| ES2483735T3 (es) | 2014-08-07 |
| EP2240185A4 (en) | 2012-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009210728B2 (en) | Compositions and methods for influencing recovery from strenuous physical activity | |
| RU2651277C2 (ru) | Композиции и способы для повышения физической работоспособности | |
| AU2022396828A1 (en) | Methods and compositions for providing a health benefit in an animal | |
| AU2019398887B2 (en) | Methods for increasing fat oxidation or energy expenditure or satiety in an animal | |
| EP2014175B1 (en) | Compositions and methods for reducing stool volume and stool odor | |
| US20110162981A1 (en) | Methods and compositions for preventing, reducting or treating damage caused by ischemia and schemia-like conditions | |
| US20250268280A1 (en) | Compositions and methods for dehydrated pet food blends | |
| CN113163801A (zh) | 用于增强动物的代谢健康的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20140131 |
|
| MKLA | Lapsed |
Effective date: 20210205 |